Suppr超能文献

胰腺癌的早期检测与预防:如今真的可行吗?

Early detection and prevention of pancreatic cancer: is it really possible today?

作者信息

Del Chiaro Marco, Segersvärd Ralf, Lohr Matthias, Verbeke Caroline

机构信息

Marco Del Chiaro, Ralf Segersvärd, Matthias Löhr, Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, 141 86 Stockholm, Sweden.

出版信息

World J Gastroenterol. 2014 Sep 14;20(34):12118-31. doi: 10.3748/wjg.v20.i34.12118.

Abstract

Pancreatic cancer is the 4(th) leading cause of cancer-related death in Western countries. Considering the low incidence of pancreatic cancer, population-based screening is not feasible. However, the existence of a group of individuals with an increased risk to develop pancreatic cancer has been well established. In particular, individuals suffering from a somatic or genetic condition associated with an increased relative risk of more than 5- to 10-fold seem to be suitable for enrollment in a surveillance program for prevention or early detection of pancreatic cancer. The aim of such a program is to reduce pancreatic cancer mortality through early or preemptive surgery. Considering the risk associated with pancreatic surgery, the concept of preemptive surgery cannot consist of a prophylactic removal of the pancreas in high-risk healthy individuals, but must instead aim at treating precancerous lesions such as intraductal papillary mucinous neoplasms or pancreatic intraepithelial neoplasms, or early cancer. Currently, results from clinical trials do not convincingly demonstrate the efficacy of this approach in terms of identification of precancerous lesions, nor do they define the outcome of the surgical treatment of these lesions. For this reason, surveillance programs for individuals at risk of pancreatic cancer are thus far generally limited to the setting of a clinical trial. However, the acquisition of a deeper understanding of this complex area, together with the increasing request for screening and treatment by individuals at risk, will usher pancreatologists into a new era of preemptive pancreatic surgery. Along with the growing demand to treat individuals with precancerous lesions, the need for low-risk investigation, low-morbidity operation and a minimally invasive approach becomes increasingly pressing. All of these considerations are reasons for preemptive pancreatic surgery programs to be undertaken in specialized centers only.

摘要

在西方国家,胰腺癌是癌症相关死亡的第四大原因。鉴于胰腺癌发病率较低,基于人群的筛查并不可行。然而,已明确存在一组患胰腺癌风险增加的个体。特别是,患有与相对风险增加5至10倍以上相关的体细胞或遗传疾病的个体似乎适合纳入胰腺癌预防或早期检测的监测项目。此类项目的目的是通过早期或预防性手术降低胰腺癌死亡率。考虑到胰腺手术相关风险,预防性手术的概念不能包括对高危健康个体进行胰腺预防性切除,而必须旨在治疗癌前病变,如导管内乳头状黏液性肿瘤或胰腺上皮内瘤变,或早期癌症。目前,临床试验结果并未令人信服地证明这种方法在识别癌前病变方面的有效性,也未明确这些病变手术治疗的结果。因此,迄今为止,针对胰腺癌高危个体的监测项目通常仅限于临床试验环境。然而,随着对这一复杂领域的深入理解,以及高危个体对筛查和治疗需求的增加,胰腺病学家将迎来预防性胰腺手术的新时代。随着治疗癌前病变个体需求的增加,对低风险检查、低发病率手术和微创方法的需求变得越来越迫切。所有这些因素都表明,预防性胰腺手术项目应仅在专科中心开展。

相似文献

2
Pancreatic cancer: advances in treatment.胰腺癌:治疗进展
World J Gastroenterol. 2014 Jul 28;20(28):9354-60. doi: 10.3748/wjg.v20.i28.9354.
7
Early detection of pancreatic cancer using DNA-based molecular approaches.利用基于 DNA 的分子方法早期检测胰腺癌。
Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):457-468. doi: 10.1038/s41575-021-00470-0. Epub 2021 Jun 7.

引用本文的文献

5
Early detection of pancreatic cancer in the era of precision medicine.精准医学时代的胰腺癌早期检测。
Abdom Radiol (NY). 2024 Oct;49(10):3559-3573. doi: 10.1007/s00261-024-04358-w. Epub 2024 May 18.
7
Radiomics advances in the evaluation of pancreatic cystic neoplasms.胰腺囊性肿瘤评估中的影像组学进展。
Heliyon. 2024 Jan 30;10(3):e25535. doi: 10.1016/j.heliyon.2024.e25535. eCollection 2024 Feb 15.

本文引用的文献

8
Current status of screening for colorectal cancer.结直肠癌筛查的现状。
Ann Oncol. 2013 Aug;24(8):1963-72. doi: 10.1093/annonc/mdt157. Epub 2013 Apr 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验